Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications

By Elsevier, PRNE
Wednesday, June 15, 2011

AMSTERDAM, June 16, 2011 -

and Journal
Help Researchers Narrow Search Results

Elsevier, a world-leading provider of scientific, technical and
medical information products and services, today announced two new
applications from Molecular Connections, a life science informatics
company, on SciVerse
Applications beta.

Ask Extractor is an application based on Molecular Connections
XTractor, a platform for discovery, analysis and modelling of
biomedical information. The application provides search suggestions
for life sciences terms entered into href="www.hub.sciverse.com">SciVerse Hub and href="www.sciencedirect.com">SciVerse ScienceDirect. The
second application, Journal Trends, enables users to discover top
journals as a result of a given search query.

“Due to the enormous amount of published scientific information,
applications that refine and simplify search results, or assist in
creating a targeted query, can significantly benefit researcher
workflows,” said Vidyendra Sadanand, Chief Technology Officer of
Molecular Connections.

“Molecular Connections has significant expertise in providing
solutions to the life science research community,” said Rafael
, Vice President, Application Marketplace and Developer Network
at Elsevier. “We look forward to continuing our work with Molecular
Connections and the developer community to deliver applications
that will improve researchers’ productivity.”

Applications and the href="developers.sciverse.com/">Developer Network
provide opportunities for researchers and librarians to collaborate
with developers in creating and promoting new applications that
improve research workflows. The Developer Network features a
growing community of application developers that gain potential
recognition, prestige and revenue through their contributions to
SciVerse Applications.

About Molecular Connections

Molecular Connections ( href="www.molecularconnections.com">www.molecularconnections.com)
is a pioneering In silico Discovery Services Company. It provides
high quality, cost effective curation, literature informatics
solutions and annotation services as well as products. Customers of
Molecular Connections include leading pharmaceutical and
biotechnology, drug discovery, genomics, proteomics, medical
technology, equipment companies and academic institutions spanning
across the globe. In addition, Molecular Connections has powerful
tool development, database integration, effective data
visualization capabilities, specific expertise in building
knowledge bases for rapidly growing needs in, ADME Tox, clinical,
drugs, chemistry and patent industries. For more information write
to Krishna Chinnaia at href="mailto:krishna@molecularconnections.com">krishna@molecularconnections.com.

About the Elsevier SciVerse Suite

The SciVerse ( href="www.sciverse.com">www.sciverse.com)suite of
search and discovery offerings provides the global research
community access to a constantly expanding universe of content and
solutions which can now be accessed in one platform. The suite
currently includes SciVerse ScienceDirect ( href="www.sciencedirect.com">www.sciencedirect.com),
the world’s largest source of peer-reviewed content containing more
than 10 million articles, and SciVerse Scopus ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.scopus.com">
www.scopus.com), an abstract and citation database
containing 41 million records, 70% with abstracts and nearly 18,000
titles from 5,000 publishers worldwide. The platform also includes
SciVerse Hub beta ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.hub.sciverse.com">
www.hub.sciverse.com), which enables researchers to
perform a single search across all of the SciVerse content as well
as targeted web content with results ranked by relevancy and
without duplication. SciVerse Applications ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.applications.sciverse.com">
www.applications.sciverse.com) and Developer Network ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.developers.sciverse.com">
www.developers.sciverse.com) allow the scientific
community to build, find and use applications that enhance the
SciVerse research experience.

About Elsevier

Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to
publish more than 2,000 journals, including The Lancet ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.thelancet.com">
www.thelancet.com) and Cell ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.cell.com">
www.cell.com), and close to 20,000 book titles,
including major reference works from Mosby and Saunders. Elsevier’s
online solutions include SciVerse ScienceDirect ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.sciencedirect.com">
www.sciencedirect.com), SciVerse Scopus ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.scopus.com">
www.scopus.com), Reaxys ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.reaxys.com">
www.reaxys.com), MD Consult ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.mdconsult.com">
www.mdconsult.com) and Nursing Consult ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.nursingconsult.com">
www.nursingconsult.com), which enhance the productivity
of science and health professionals, and the SciVal suite ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.scival.com">
www.scival.com) and MEDai’s Pinpoint Review ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.medai.com">
www.medai.com), which help research and health care
institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.elsevier.com">
www.elsevier.com) employs 7,000 people worldwide. The
company is part of Reed Elsevier Group PLC ( href="file:///\\nysvr\nyfiles\NY%20Client%20Files\27600%20--%20Elsevier\2011\Media%20Relations\Press%20Releases\www.reedelsevier.com">
www.reedelsevier.com), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC
and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York
Stock Exchange).

Media contact

Sandra Plasse


will not be displayed